Factors Associated With Morbidity and Retreatment After Surgical Management of Nonacute Subdural Hematomas in Elderly Patients
- PMID: 35673314
- PMCID: PMC9165920
- DOI: 10.7759/cureus.24779
Factors Associated With Morbidity and Retreatment After Surgical Management of Nonacute Subdural Hematomas in Elderly Patients
Abstract
Background Preoperative identification of clinical, radiographic, and surgery-specific factors associated with nonacute subdural hematomas (SDHs) may enable clinicians to optimize the efficacy of the initial surgical intervention, improve outcomes, and decrease rates of surgical recurrence. Methods The authors identified patients aged ≥65 years who underwent surgical treatment of chronic, subacute, or mixed-density SDH at a level-1 trauma hospital over a ten-year period (2010-2019). Pre-and postoperative clinical, radiographic, and surgery-specific data were collected. Predictors of surgical recurrence as well as morbidity, mortality, and discharge disposition were analyzed. Results There were 268 nonacute SDHs treated surgically; 46 were chronic, 19 were subacute, and 203 were mixed density. Of these, 179 were treated with burr hole(s), 62 with miniature craniotomy, and 27 via a large craniotomy and removal of subdural membranes. Statin use was protective (OR 0.22; 95% CI 0.08, 0.60) against recurrence requiring reoperation. Preoperative use of antithrombotic agents was not significantly associated with increased recurrence requiring reoperation. Smaller preoperative hematoma thickness was associated with significantly lower mortality risk, whereas mixed-density hematomas, patient age, change in thickness after surgery, density, and presence of cisternal effacement were significantly associated with discharge disposition. Hematoma type was also associated with hospital and intensive care length of stay. Conclusions Our experience suggests that, in elderly patients, premorbid statin usage is associated with lower recurrence rates and preoperative antithrombotic use does not affect recurrence when appropriately reversed before surgery. Patient age, preoperative thickness, and hematoma type contribute to postoperative outcomes such as discharge disposition and length of stay.
Keywords: burr hole; chronic; craniotomy; mixed density; recurrence; statins; subacute; subdural hematoma.
Copyright © 2022, Bounajem et al.
Conflict of interest statement
The authors have declared financial relationships, which are detailed in the next section.
Figures
Similar articles
-
A case-comparison study of the subdural evacuating port system in treating chronic subdural hematomas.J Neurosurg. 2010 Sep;113(3):609-14. doi: 10.3171/2009.11.JNS091244. J Neurosurg. 2010. PMID: 20001585
-
Predictors and Outcomes of Subdural Hematomas Managed via Subdural Evacuation Port System.World Neurosurg X. 2022 Oct 5;17:100145. doi: 10.1016/j.wnsx.2022.100145. eCollection 2023 Jan. World Neurosurg X. 2022. PMID: 36341136 Free PMC article.
-
Risk factors for reoperation after initial burr hole trephination in chronic subdural hematomas.Clin Neurol Neurosurg. 2015 Nov;138:66-71. doi: 10.1016/j.clineuro.2015.08.002. Epub 2015 Aug 5. Clin Neurol Neurosurg. 2015. PMID: 26282910
-
Chronic subdural hematoma: the role for craniotomy reevaluated.Neurosurgery. 1993 Jul;33(1):67-72. doi: 10.1227/00006123-199307000-00010. Neurosurgery. 1993. PMID: 8355849 Review.
-
The Neurocritical and Neurosurgical Care of Subdural Hematomas.Neurocrit Care. 2016 Apr;24(2):294-307. doi: 10.1007/s12028-015-0194-x. Neurocrit Care. 2016. PMID: 26399248 Review.
Cited by
-
Comparative analysis of surgical techniques in the management of chronic subdural hematomas and risk factors for poor outcomes.Neurosurg Rev. 2024 Jul 18;47(1):338. doi: 10.1007/s10143-024-02581-z. Neurosurg Rev. 2024. PMID: 39023653 No abstract available.
-
Investigation of Neutrophil Extracellular Traps as Potential Mediators in the Pathogenesis of Non-Acute Subdural Hematomas: A Pilot Study.Diagnostics (Basel). 2022 Nov 24;12(12):2934. doi: 10.3390/diagnostics12122934. Diagnostics (Basel). 2022. PMID: 36552941 Free PMC article.
References
-
- Trend in outcome and financial impact of subdural hemorrhage. Frontera JA, de los Reyes K, Gordon E, et al. Neurocrit Care. 2011;14:260–266. - PubMed
-
- Total 1-year hospital cost of middle meningeal artery embolization compared to surgery for chronic subdural hematomas: a propensity-adjusted analysis. Catapano JS, Koester SW, Srinivasan VM, et al. J Neurointerv Surg. 2021 - PubMed
-
- Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Mori K, Maeda M. Neurol Med Chir (Tokyo) 2001;41:371–381. - PubMed
-
- Hospital costs, incidence, and inhospital mortality rates of traumatic subdural hematoma in the United States. Kalanithi P, Schubert RD, Lad SP, Harris OA, Boakye M. J Neurosurg. 2011;115:1013–1018. - PubMed
LinkOut - more resources
Full Text Sources